◀ Back to JUN
FOSL1 — JUN
Pathways - manually collected, often from reviews:
-
FastForward regulation:
JUN
→
FOSL1
(transcriptional regulation, increase)
Smith et al., Oncogene 1999*
Evidence: REG
-
NCI Pathway Database Validated transcriptional targets of AP1 family members Fra1 and Fra2:
Fra1 (FOSL1)
→
JUN (JUN)
(modification, collaborate)
Young et al., Mol Cell Biol 2002*, Kovary et al., Mol Cell Biol 1992*, Burch et al., Mol Cell Biol 2004*, Chalmers et al., Cell Signal 2007*, Basbous et al., Mol Cell Biol 2007*, Ryseck et al., Oncogene 1991, Suzuki et al., Nucleic Acids Res 1991, Malnou et al., J Biol Chem 2010*, Talotta et al., Oncogene 2010*, Cohen et al., Genes Dev 1989*, Rauscher et al., Science 1988*, Gruda et al., Oncogene 1994*, Treinies et al., Mol Cell Biol 1999*, Cook et al., Mol Cell Biol 1999*
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database Validated transcriptional targets of AP1 family members Fra1 and Fra2:
Fra1 (FOSL1)
→
Fra1/JUN complex (FOSL1-JUN)
(modification, collaborate)
Young et al., Mol Cell Biol 2002*, Kovary et al., Mol Cell Biol 1992*, Burch et al., Mol Cell Biol 2004*, Chalmers et al., Cell Signal 2007*, Basbous et al., Mol Cell Biol 2007*, Ryseck et al., Oncogene 1991, Suzuki et al., Nucleic Acids Res 1991, Malnou et al., J Biol Chem 2010*, Talotta et al., Oncogene 2010*, Cohen et al., Genes Dev 1989*, Rauscher et al., Science 1988*, Gruda et al., Oncogene 1994*, Treinies et al., Mol Cell Biol 1999*, Cook et al., Mol Cell Biol 1999*
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database Validated transcriptional targets of AP1 family members Fra1 and Fra2:
JUN (JUN)
→
Fra1/JUN complex (FOSL1-JUN)
(modification, collaborate)
Young et al., Mol Cell Biol 2002*, Kovary et al., Mol Cell Biol 1992*, Burch et al., Mol Cell Biol 2004*, Chalmers et al., Cell Signal 2007*, Basbous et al., Mol Cell Biol 2007*, Ryseck et al., Oncogene 1991, Suzuki et al., Nucleic Acids Res 1991, Malnou et al., J Biol Chem 2010*, Talotta et al., Oncogene 2010*, Cohen et al., Genes Dev 1989*, Rauscher et al., Science 1988*, Gruda et al., Oncogene 1994*, Treinies et al., Mol Cell Biol 1999*, Cook et al., Mol Cell Biol 1999*
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database Validated transcriptional targets of AP1 family members Fra1 and Fra2:
Fra1/FIAT complex (FOSL1-TXLNG)
→
Fra1/JUN complex (FOSL1-JUN)
(transcription, inhibits)
Farzaneh-Far et al., J Biol Chem 2001*, Eferl et al., EMBO J 2004*, Julien et al., J Bone Miner Res 2009*, St-Arnaud et al., Ann N Y Acad Sci 2010*
Evidence: reporter gene, physical interaction
-
NCI Pathway Database AP-1 transcription factor network:
Fra1 (FOSL1)
→
JUN (JUN)
(modification, collaborate)
Young et al., Mol Cell Biol 2002*, Malnou et al., J Biol Chem 2010*, Talotta et al., Oncogene 2010*, Cohen et al., Genes Dev 1989*, Gruda et al., Oncogene 1994*
Evidence: physical interaction
-
NCI Pathway Database AP-1 transcription factor network:
Fra1 (FOSL1)
→
Fra1/JUN complex (FOSL1-JUN)
(modification, collaborate)
Young et al., Mol Cell Biol 2002*, Malnou et al., J Biol Chem 2010*, Talotta et al., Oncogene 2010*, Cohen et al., Genes Dev 1989*, Gruda et al., Oncogene 1994*
Evidence: physical interaction
-
NCI Pathway Database AP-1 transcription factor network:
JUN (JUN)
→
Fra1/JUN complex (FOSL1-JUN)
(modification, collaborate)
Young et al., Mol Cell Biol 2002*, Malnou et al., J Biol Chem 2010*, Talotta et al., Oncogene 2010*, Cohen et al., Genes Dev 1989*, Gruda et al., Oncogene 1994*
Evidence: physical interaction
-
NCI Pathway Database Validated transcriptional targets of AP1 family members Fra1 and Fra2:
Fra1/FIAT complex (FOSL1-TXLNG)
→
Fra1/JUN complex (FOSL1-JUN)
(transcription, inhibits)
Chandrasekar et al., J Biol Chem 2006*, St-Arnaud et al., Ann N Y Acad Sci 2010*
Evidence: reporter gene, physical interaction
-
WikiPathways Wnt Signaling Pathway and Pluripotency:
EP300
→
Complex of 11 proteins
(activation)
-
WikiPathways Wnt Signaling Pathway and Pluripotency:
ZBTB33
→
Complex of 11 proteins
(mim-inhibition)
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
-
IRef Bind Interaction:
FOSL1
—
JUN
Newman et al., Science 2003
-
IRef Bind_translation Interaction:
FOSL1
—
JUN
(array technology)
Newman et al., Science 2003
-
IRef Biogrid Interaction:
FOSL1
—
JUN
(direct interaction, fluorescent resonance energy transfer)
Reinke et al., Science 2013
-
IRef Biogrid Interaction:
FOSL1
—
JUN
(direct interaction, two hybrid)
Pognonec et al., Oncogene 1997*
-
IRef Biogrid Interaction:
FOSL1
—
JUN
(direct interaction, pull down)
Pognonec et al., Oncogene 1997*
-
IRef Biogrid Interaction:
FOSL1
—
JUN
(physical association, affinity chromatography technology)
Kumar et al., J Biol Chem 2001*
-
IRef Hprd Interaction:
FOSL1
—
JUN
(in vitro)
Udalova et al., Biochem Biophys Res Commun 2001*, Jardine et al., J Biol Chem 2002*
-
IRef Hprd Interaction:
FOSL1
—
JUN
(in vivo)
Udalova et al., Biochem Biophys Res Commun 2001*, Jardine et al., J Biol Chem 2002*
-
IRef Ophid Interaction:
FOSL1
—
JUN
(aggregation, interologs mapping)
Brown et al., Bioinformatics 2005
-
IRef Ophid Interaction:
FOSL1
—
JUN
(aggregation, confirmational text mining)
Udalova et al., Biochem Biophys Res Commun 2001*
Text-mined interactions from Literome
Young et al., Mol Cell Biol 2002
(Cell Transformation, Neoplastic) :
These observations suggest that ERK dependent activation of
Fra-1 is
required for
AP-1 transactivation in JB6 cells
Adiseshaiah et al., J Biol Chem 2003
:
In particular, coexpression of
c-Jun , Jun-D, and Fra-2
up-regulated fra-1 transcription
Vial et al., J Cell Sci 2003
(Colonic Neoplasms) :
We show that
c-JUN and FRA-1 expression is dependent on ERK activity and that different thresholds of ERK activity
control the expression of
FRA-1
Yang et al., Pigment Cell Res 2004
(Melanoma) :
In w3211, c-Jun, JunD and
Fra-1 were
involved in
AP-1 binding, while in w1205, overall AP-1 binding activity was decreased significantly and supershift binding was detected only with JunD antibodies
Myhrstad et al., Nutr Cancer 2006
(Carcinoma, Hepatocellular...) :
Fra-1 is a member of the activator protein 1 (AP-1) family of transcription factors and, due to the lack of transactivation domain Fra-1, can
suppress activation of
AP-1
Camalier et al., Cancer prevention research (Philadelphia, Pa.) 2010
(Cell Transformation, Neoplastic...) :
Supplementation of medium with phosphate increased anchorage independent transformation and proliferation of BALB/c mouse JB6 epidermal cells,
activation of N-ras, ERK1/2, and
activator protein-1 , and increased gene expression of
Fra-1 , COX-2, and osteopontin in a dose dependent manner
Yoshioka et al., Proc Natl Acad Sci U S A 1995
:
Furthermore,
Fra-1 repressed
AP-1 activity induced by either TPA or expression of c-Jun and c-Fos
Bergers et al., Mol Cell Biol 1995
(Cell Transformation, Neoplastic) :
Transcriptional
activation of the
fra-1 gene by
AP-1 is mediated by regulatory sequences in the first intron ... Constitutive expression of c-Fos, FosB, Fra-1, or
c-Jun in rat fibroblasts
leads to up-regulation of the immediate-early gene
fra-1 ... Using the posttranslational FosER induction system, we demonstrate that this
AP-1 dependent stimulation of
fra-1 expression is rapid, depends on a functional DNA binding domain of FosER, and is a general phenomenon observed in different cell types ... In vitro mutagenesis and functional analysis of the rat fra-1 gene in stably transfected Rat-1A-FosER fibroblasts indicated that basal and
AP-1 regulated expression of the
fra-1 gene depends on regulatory sequences in the first intron which comprise a consensus AP-1 site and two AP-1-like elements
Schreiber et al., Oncogene 1997
(Osteosclerosis) :
Absence of c-Fos leads to significantly reduced serum stimulation of fra-1 expression in gene targeted mouse fibroblasts, demonstrating that mitogen induction of
fra-1 is partially
mediated by
c-Fos/AP-1
Casamassimi et al., Cancer Res 1998
:
Fra-1 and c-jun were
induced by p53, resulting in increased
AP-1 levels
Kustikova et al., Mol Cell Biol 1998
(Adenocarcinoma...) :
We found that the enhanced level of
AP-1 in CSML100 cells was
due to high expression of
Fra-1 and Fra-2 proteins, which were undetectable in CSML0 nuclear extracts
Cook et al., Mol Cell Biol 1999
:
c-Fos,
c-Jun , and JunB are
induced rapidly in response to LPA stimulation, whereas
Fra-1 and Fra-2 are induced after a significant lag ... In cells expressing a conditionally active form of Raf-1 ( DeltaRaf-1 : ER ), we observed that selective, sustained activation of Raf-MEK-MAPK was sufficient to induce expression of
Fra-1 , Fra-2, and JunB but, interestingly,
induced little or no c-Fos or
c-Jun